Safety, activity and biomarkers of atezolizumab (MPDL3280A) with platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): A Phase Ib study

被引：11

作者：

Giaccone, G. ^{[1
]}

Camidge, D. R. ^{[2
]}

Liu, S. V. ^{[1
]}

Powderly, J. ^{[3
]}

Hodi, F. S. ^{[4
]}

Gettinger, S. N. ^{[5
]}

Heist, R. S. ^{[6
]}

Liu, B. ^{[7
]}

Wallin, J. ^{[7
]}

Funke, R. ^{[7
]}

Waterkamp, D. ^{[7
]}

Ready, N. E. ^{[6
]}

机构：

[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Carolina BioOncol Inst, Huntersville, NC USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Yale Canc Ctr, New Haven, CT USA

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Genentech Inc, San Francisco, CA 94080 USA

来源：

关键词：

D O I：

10.1016/S0959-8049(16)30314-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

513

引用

页码：S107 / S108

页数：2